0001562180-15-000300.txt : 20150420
0001562180-15-000300.hdr.sgml : 20150420
20150420170851
ACCESSION NUMBER: 0001562180-15-000300
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150416
FILED AS OF DATE: 20150420
DATE AS OF CHANGE: 20150420
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tokai Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001404281
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 Broadway
STREET 2: 14TH FLOOR
CITY: Cambridge
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-225-4348
MAIL ADDRESS:
STREET 1: 1 Broadway
STREET 2: 14TH FLOOR
CITY: Cambridge
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kalowski Lee
CENTRAL INDEX KEY: 0001618273
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36620
FILM NUMBER: 15781217
MAIL ADDRESS:
STREET 1: C/O TOKAI PHARMACEUTICALS, INC.
STREET 2: ONE BROADWAY, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2015-04-16
false
0001404281
Tokai Pharmaceuticals Inc
TKAI
0001618273
Kalowski Lee
C/O TOKAI PHARMACEUTICALS, INC.
255 STATE STREET 6TH FLOOR
BOSTON
MA
02109
false
true
false
false
Chief Financial Officer
Common Stock
2015-04-16
4
S
false
4567.00
13.00
D
47779.00
D
The sale reported on this Form 4 was effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon vesting.
/s/ Cindy Driscoll, Attorney-in-Fact
2015-04-20